297 related articles for article (PubMed ID: 34358309)
1. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
[TBL] [Abstract][Full Text] [Related]
2. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice.
Wang J; Song Y; Zhang Y; Xiao H; Sun Q; Hou N; Guo S; Wang Y; Fan K; Zhan D; Zha L; Cao Y; Li Z; Cheng X; Zhang Y; Yang X
Cell Res; 2012 Mar; 22(3):516-27. PubMed ID: 21844895
[TBL] [Abstract][Full Text] [Related]
6. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
[TBL] [Abstract][Full Text] [Related]
7. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
Xu X; Wang J; Wang X
Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
9. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
11. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H
Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T
J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833
[TBL] [Abstract][Full Text] [Related]
15. Visfatin aggravates transverse aortic constriction-induced cardiac remodelling by enhancing macrophage-mediated oxidative stress in mice.
Shen C; Fang R; Wang J; Wu N; Wang S; Shu T; Dai J; Feng M; Chen X
J Cell Mol Med; 2023 Sep; 27(17):2562-2571. PubMed ID: 37584247
[TBL] [Abstract][Full Text] [Related]
16. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
18. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
[TBL] [Abstract][Full Text] [Related]
19. Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts.
Yang Z; Xiao Z; Guo H; Fang X; Liang J; Zhu J; Yang J; Li H; Pan R; Yuan S; Dong W; Zheng XL; Wu S; Shan Z
J Cell Mol Med; 2019 May; 23(5):3246-3256. PubMed ID: 30729664
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p.
Ni H; Li W; Zhuge Y; Xu S; Wang Y; Chen Y; Shen G; Wang F
Int J Cardiol; 2019 Oct; 292():188-196. PubMed ID: 30967276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
